Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
5.40
-0.59 (-9.85%)
Feb 21, 2025, 4:00 PM EST - Market closed
CELZ Market Cap
CELZ has a market cap or net worth of $9.44 million as of February 21, 2025. Its market cap has increased by 60.03% in one year.
Market Cap
9.44M
Enterprise Value
3.20M
1-Year Change
60.03%
Ranking
Category
Stock Price
$5.40
Market Cap Chart
Since December 11, 2017, CELZ's market cap has increased from $2.70M to $9.44M, an increase of 249.69%. That is a compound annual growth rate of 18.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 9.40M | 135.00% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | 0.63% |
| Dec 31, 2020 | 16.00M | 2,185.71% |
| Dec 31, 2019 | 700.00K | -91.03% |
| Dec 31, 2018 | 7.80M | 457.14% |
| Dec 29, 2017 | 1.40M | -48.15% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |